KRT17 Antibody (C-term) Blocking peptide
€363.00
In stock
SKU
AC-BP13426b
Background:
This gene encodes the type I intermediate filament chainkeratin 17, expressed in nail bed, hair follicle, sebaceous glands,and other epidermal appendages. Mutations in this gene lead toJackson-Lawler type pachyonychia congenita and steatocystomamultiplex.
Other Names:
Keratin, type I cytoskeletal 17, Cytokeratin-17, CK-17, Keratin-17, K17, KRT17
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP13426b was selected from the C-term region of KRT17. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: KRT17
Gene ID: 3872
Primary Accession: Q04695
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
This gene encodes the type I intermediate filament chainkeratin 17, expressed in nail bed, hair follicle, sebaceous glands,and other epidermal appendages. Mutations in this gene lead toJackson-Lawler type pachyonychia congenita and steatocystomamultiplex.
Other Names:
Keratin, type I cytoskeletal 17, Cytokeratin-17, CK-17, Keratin-17, K17, KRT17
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP13426b was selected from the C-term region of KRT17. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: KRT17
Gene ID: 3872
Primary Accession: Q04695
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review